Advances in synthetic siRNA delivery

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• RNA interference (RNAi) utilizes small interfering RNAs (siRNAs) for gene silencing, offering therapeutic potential for various diseases including cancer and viral infections.
• Effective siRNA therapy requires cellular uptake, cytoplasmic entry, and loading onto the Argonaute protein within the RNA-induced silencing complex (RISC) to mediate transcript cleavage.

Purpose of the Study:

• To review recent advancements in non-viral delivery strategies for small interfering RNAs (siRNAs).
• To highlight progress in targeted siRNA delivery to specific tissues and cell types in vivo using preclinical animal models.

Main Methods:

• Review of current literature on RNA interference (RNAi) and siRNA delivery systems.
• Focus on non-viral delivery approaches, including those enabling targeted delivery.

Main Results:

• Development of diverse novel siRNA delivery strategies.
• Increased understanding of RNAi pathway mechanisms facilitates rational design of effective silencing and delivery systems.
• Preclinical studies demonstrate the utility of targeted siRNA delivery in animal models.

Conclusions:

• Non-viral siRNA delivery methods are rapidly evolving.
• Targeted delivery strategies are crucial for enhancing siRNA therapeutic efficacy and specificity in vivo.
• Continued research in siRNA delivery holds significant promise for future disease treatments.